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is features of hypertrophic cardiomyopathy 
nizsd in numerous reports (t-4). As a 
primary disorder of heart muscle. hypertrophis cardiomyop 
athy is often associated with abnormal Icft ventricular sys- 
tolic and diastolic function and rhythm disturbau~es (5.61. 
ly believed to be a 
en death, with an annual attrition 
in patients without ventricular 
s In addition. family history of sudden death, 
been identified as 
(8-11). Even though 
onitoring results are 
helpful in identifying some factors associated with sudden 
death. predictors of syncope have not been analyzed in 
hfD. Department d Int 
patients with by~ertro~h~c cnrdiom 
there is no reliable clinical risk strati 
this “malignant” symptom associated with sudden death (4). 
the purpose of this study was to isoll 
factors and describe variables associ 
s 
nt de&m. Twenty-nine patients (18 men and 1 I 
wo with echocardiographic evidence of hypertrophic 
ca~iomyop~thy participated in tlris study (6); their mean 
8 2 12.2 years (range %I to 63). Demographic d 
ms and the administration of long-term medication 
are listed in Table 1. No patient had luminal narrowing of 
any coronary artery, but four patients (13%) revealed mild 
(I t ) mitrd re~ur~itatioa on the contrast vemtriculogram; all 
were in sinus rhythm and cardiovascular drugs were with- 
drawn for at least 48 h before study. All patients gave w~~~~~ 
informed consent for the protocol approved by the Univer- 
sity Hospital Ethics Committee. 
P&Ws M’ere stratified in two groups according to his- 
my ~~~~ ~~~~~t~t}~s~ 8 atients with witnessed docu ted 
syncope formed group I, and 19 patients without syncopal 
events but with spontaneous or effort-related dyspnea, or 
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Numbers in paren(hcscs denote number of syncopal cvcnls. F = k!mak!: 
M = male. 
array scanner (80”) with a 3.0 
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Table 2. Clinical, Morphologic and !Iemodynamic Characteristics 
of 29 ?atients 
Group I 
(II = 8) 
Group II 
rn = ?I) p Vnlur 
Clinical data 
Age (yr) 
Age C30 yr 
No. of men 
NYHA class 111 
Exertional chest pain 
Seplumlpoalarior wall 
Septal thickness (mm) 
SAM 
LA diamslcr (mm) 
H 
Rest LV gndient 
Provokablc LV 
gradient 
LVEDP (mm Hg) 
RVEDP (mm Hg) 
mAOF (mm Hg) 
31 + IO 50 c 8 
6 (75%) 0 
4 (50%) 13 (67%) 
3 (37.5%‘0) 4 (19%) 
7 (87.5%) 16 (80%) 
Jb2 
7 (3.141 
5 (24%) 
3 (14.3%) 
1.7 zr .5 
21 t 5 
3 (14%) 
37 * 9 
12.5 + 17.1 76.3 c 34.7 
4 (SW 
3 (375%) 
8 (38%) 
5 (24%) 
20 ?: 5 
321 
84 2 7 
I6 f 9 
423 
93 ” IO 
0.001 
0.003 
NS 
NS 
NS 
0.603 
O.OOI3 
0.01 
NS 
0*01)17 
0.014 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
0.023 
LA = IcR atrial: LV = let\ ventriclr: LVEDP = IcR vemricular end- 
diastolic pressure; mAOP = mean aortic pressure: NYHA class = New York 
HWI Association functional class; RVEDP 2: right vsntriculnr end-duetohs 
pressure; SAM 1s systolic anterior motion of ths mitral vulvs. 
~A~/~1 x 80, where PAP = mean pulmoni\ry artcry prcs- 
sure: and pulmonnry vasculur resistance index WW) = 
reverse W wave gting, a sequence of cardiac images was 
acquired in the list mode (15) by a PBP I I omputer with 
gamma-l I sefiware. Approximately 880 counts were 
accumulated in the end-diastolic region of interest. High 
resolution (IO 10 20 rns~f~rne~ time~activity curves 
etated from left ventricular and back~~uad regions 
ms was framed at a rate 
d-systole was measured 
the time-activity curve. Peak 
e maximal slope of a third 
ynominal function Wed to the filling phase by a 
technique (16). Time to peak filling rate was 
measured from end-systole to the time of peak left ventric- 
ular filling rate. The majority of time-activity curves at rest 
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have a visually appreciable relaxation perio 
by an interval of horizontal or slightly posi 
jetted between the inimal left ventricular 
onset of rapid diastolic filling. The point of i 
terminated the isovo~um~t~c relaxatio 
determined according to the method by 
Left ventricular end-diastolic volume 
calculated by dividing stroke volume i 
lar ejection fraction, where left ve 
volume index (~~~~~~~ = LVE 
these ca~c~~~tions, tbc peak 
normalized to the tr;le end-d 
as ml/s. Two sets of b~se~i~c rnc~~s~lr 
10 min intervals. Alli me~suref~~~ls 
the heart r;ue increased by 
beatslmin until a syrnPtorn~li~~~t~~ 
tdyspnca, angina or diazincss). 
with high grade ven 
~35 mm from the su~~ce I% lead E 
descried protocol (20). 
catheters (i~tere~ect~ode 
His bundle potential and in the rigkt 
apex. A Siemens 16 channel electroca~ 
HIS, Biotronik GmbH) was used to deliver rect 
pulses of I ms and a constant current of twice diastolic 
e~tricular extrastimuli were delivered duri 
nd at three different paced drive cycle lengt 
44~ ms) using the single extrastimulus tech- 
nique. Ventricular pacing was pe~orme~ first from tire rig 
and then from the left ventricle. During sinus rhythm, a 
maximum of two extrastimuli was delivered: S2 was applied 
er the last S,, progressively approaching 
ffective refractory period in steps of PO ms. 
failed to induce a sustained arrhythmia, it was set at 20 ms 
outside the refractory period and a second ventricular ex- 
trastimulus 6,) was added 400 ms after S2. An induced 
For a given variable x, t 
its relation to 1 
the target evemt and 
ope (group I) were 
art Association f~~ctio~a~ class. T 
pattern, as described by Maron et al. ( 129, was more freshest 
0.01). The incidence and magnitude of left 
ruction were similar in the two groups: in 
group I, four patients (50%) had a rest gradient of 72.5 ” 17. I 
I 
2 (9.5%; 
t I (52.4%) 
9.72 lb 
9 (9 5%) 1 . 
4 (WX9 
0.01) ejection fraction. In 
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4, Rest Hemodynamic and Radionuclide Data in 29 Patients 
Group I 
!n -5 .?! 
croup !I 
iii = 2it p Value 
_--- 
Hemodynumic dala 
Heart rate (betrtslmin) 
mAP (mm Hg) 
mPAP (mm Ht$ 
PCWP (mm Hgl 
mRAP (mm Hg) 
Cl (IitersImin per rn’) 
SVI (mUm”) 
SW (dynescm .sm’) 
PVRI (dyner~cm-“,rn “1 
Rndioauclide data 
LVEF (%I) 
RVEF (9%) 
PRR (ml/s) 
TFBR (mst 
PFR (mllul 
‘TPFR (ms) 
IRP (ms) 
LVEDVI (ml/m’) 
LVBSVI (ml/m9 
73 + IO 
84 t 7.1 
14.4 t 3.3 
8.0 r 2.6 
2.0 r 1.1 
3.1 L 0.65 
42 f I4 
2,176 + 456 
I71 2 71 
x3 d 4 
22 1 I2 
357 i: 82 
I29 Y: 28 
2H4 2 90 
239 $ IO2 
Ill i 15 
51.7 t IO,8 
8,s s s.a 
762 I8 
93 + IO 
4.8 9 4.7 
1.4 t 5.2 
2.2 t I.8 
3.4 -c 0.59 
469 I3 
2.186 * 473 
175 2: as 
fl4 :(: I3 
35 9 II 
338 s: 131 
I33 f 32 
2H2 s II7 
264 d 49 
76 c 28 
79.2 9 22.6 
31.6 % 13.6 
NS 
0.023 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
0.002 
0.01 
NS 
NS 
NS 
NS 
NS 
0.004 
O.(XII 
Cl - cardiac index: IRP = isovolumic relaxation period: LVEDVI = left 
ventricular et&diastolic volume index: LVEF = left ventricular ejection 
fraction; LVESVI = left ventricular end-systolic volume index: mAP = meun 
arterial pressure: mPAP = mean pulmonary artery pressure: mRAP “i meun 
right atrial pressure: PCWP = pulmonary capillary wedge pressure: PER = 
peak ejection rate: PFR = peak filling mte: PVRI = pulmonary vascular 
resistance index; RVEF = right ventricular ejection fruction: SVI = stroke 
volume index; SVRI = systemic vasculur resistsnce index: TPER = time to 
peak ejection fraction; TPFR = time to peak filling rum. 
diastolic and end-systolic volume indexes wcrc significantly 
thcr ~em(~yRamic varinblcs. including 
te were similar in 
5). The hcmodynamic a 
at maximal pacing heart rate 
nd-systolic volume indexes 
up 1. Stroke volume index 
Table 5. Hemodynamic and Radionuclide &!a at 
Symptom-Limited Pacq R&G in 23 Fattents 
.-- 
Group I Group II 
(n = 8) (n = ?I) p Value 
Hemodynamic data 
Symptom-limited pacing 
heart rate 
mAP (mm Hgt 
mPAP (mm Hg) 
PCWP (mm Hg) 
mRAP (mm Hgl 
CL (mlllmin per t-n+ 
SVI (ml/m? 
SVRI (dyne.s.cm sm”“) 
PVRI (dyne.s.cm ‘.rn “I 
Kudionuclide dam 
LVEF (‘2’) 
RVEF 1%) 
PER (mllsl 
PFH mw 
TPFR (ms) 
IRP (ms) 
LVEDVI (ml/m+ 
LVESVI (rnl~rn~~ 
120 c 17.9 
83.7 + 5.9 
20.6 2 4.9 
13.7 ?: 6.7 
4.0 c 2.6 
2.8 im I.0 
+ x.5 
?I 842 
‘3’ * lb1 Ll”” 
R8 2 IS 
24 2 9.9 
Itut ” 51 
149 v 42 
247 I 36 
taS f 70 
NM 
29.1 * 9.1 
s.7 2 5.1 
150 * 20.5 
97.0 + 23.8 0.02 
25.6 b: 5.9 NS 
17.9 9 5.7 NS 
s-i + 2.9 NS 
3.0 + 0.7 NS 
2I.O * 4.9 NS 
2,58N * 743 NS 
207 r II8 NS 
years $8 = 4.803); 2) left ventricular end- 
iacd variables was I 
patients. 
with a correct prediction in 
Age arid 72 h ~~)lt~~r ntattieorittg. Patients >30 years 01 
and with no evidence of Lawn grade lVb veatricubr ar- 
r~~t~rni~ on 72 h Molter monitorbg did not have any 
Table 6. Significant ~ndepcndeat Vurilrblcs far Exact kygistic 
Odds Ratio i3 0 Value 
Age <30 yr 121.8 4.803 0. 
LVEDVI <6O ml/n? ?7. I 3.302 I$. 
Lown IVb on 72 h ECG 13.3 2.5999 0.03 
Abbreviations as in Tables 3 and 4. 
index 
rng rate and time to pea 
relaxation time appeared to be p 
severe hypertrophy. Finally, the observation that both non- 
sustained ve~trisu~ar ta~~y~ard~a an 
Serious ventricular arr 
hit cardiomyopathy (78, 
found (7,29,30) in 25% of patients, although associated with 
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prevented circulatory collapse. Moreover, both left ventric- 
ular end-diastolic and end-systolic volume indexes were 
significantly lower at rest and at maximal pacing in group II 
(with syncope), Diastolic abnormalities may play a modulat- 
ing role, being abnormal in both groups, which is consistent 
with previous results from angiographic (23L echocardio- 
graphic (31) and radionuclide (32) studies. 
In contrast to Newman et al. (2% we could not demon- 
strate a correlation of ejection and filling rates with end- 
diastolic and stroke volume indexes or with left ventricular 
a lack of association between 
ant irn~~irm~nt of rfWmtion are 
likely to exgerienee adverse functional cons+ 
chyarrhythmias of an ind, even from sinus 
th relaxation and filli are further irn~~ir~d 
diastole and in any tachyarrhythmia by loss 
of atrial transport as 8n important compensatory mechanis9 
ation, Additional factors affecting fo~~rd 
electrically or mechanically induced disco- 
ion (ectopic ventricular activation site) and 
potentially ischamic myocardial dysfunction (33,341. 
Tithe impact of the abnormalities on circulatuty volumr 
ar a gives heart rate (pacing tachycardia) may be a frrnction 
of the extent of hypcrtrophy (27). A recent “experiment of 
nature” (35) demonstrated the deterioration of pump func- 
tion during ventricular tachycardia, Our data strongly sup 
port this concept because our patients with syncopc had R 
hype~rophy, and their 
heart rate than their spontaneous 
te the similar incidence and rate 
en syncop and sudden death. The risk 
sustained v~ntricutar 
filling volume, which 
e inducibility of ventricular arrhytb- 
ectrical stimulation failed to identify 
for syncope. Tachyarrhythmic events were 
#PUPS x+nmd are. therefore. not mecific for 
syncope, but may lead to a fatai outcome in a c~t~catty 
hypertrophied heart with a low filling volume. 
Thus, the identification f these variables allows one to 
assess the individual risk profile and may have an ~rn~act on 
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